XENETIC BIOSCIENCES, INC. Operating Expenses
XENETIC BIOSCIENCES, INC. (XBIO) reported Operating Expenses of $1.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- XENETIC BIOSCIENCES, INC. operating expenses for the quarter ending 2026-06-30 was $1.63M, a 24.19% increase year-over-year.
- XENETIC BIOSCIENCES, INC. operating expenses for the quarter ending 2026-03-31 was $1.31M, a 14.76% decline year-over-year.
- XENETIC BIOSCIENCES, INC. operating expenses for the quarter ending 2025-12-31 was $1.39M, a 20.52% decline year-over-year.
- XENETIC BIOSCIENCES, INC. operating expenses for the quarter ending 2025-09-30 was $1.57M, a 41.12% increase year-over-year.
- XENETIC BIOSCIENCES, INC. operating expenses for fiscal 2025 was $5.81M, a 13.33% decline from fiscal 2024.
- XENETIC BIOSCIENCES, INC. operating expenses for fiscal 2024 was $6.70M, a 4.97% decline from fiscal 2023.
- XENETIC BIOSCIENCES, INC. operating expenses for fiscal 2023 was $7.06M, a 16.25% decline from fiscal 2022.
- XENETIC BIOSCIENCES, INC. operating expenses for fiscal 2022 was $8.42M, a 21.97% increase from fiscal 2021.
| Period end | Operating Expenses 1 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 7 month | Operating Expenses 9 month | Operating Expenses 10 month | Operating Expenses 12 month | Operating Expenses 19 month | Operating Expenses 22 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.63M 10-Q · filed 2026-08-06 | $2.94M 10-Q · filed 2026-08-06 | $4.33M derived: sum of 3 quarters · filed 2026-08-06 | $5.90M derived: sum of 4 quarters · filed 2026-08-06 | ||||||
| 2026-03-31 | $1.31M 10-Q · filed 2026-05-12 | $2.70M derived: sum of 2 quarters · filed 2026-05-12 | $4.27M derived: sum of 3 quarters · filed 2026-05-12 | $5.58M derived: sum of 4 quarters · filed 2026-08-06 | ||||||
| 2025-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $2.96M derived: sum of 2 quarters · filed 2026-03-12 | $4.28M derived: sum of 3 quarters · filed 2026-08-06 | $5.81M 10-K · filed 2026-03-12 | ||||||
| 2025-09-30 | $1.57M 10-Q · filed 2025-11-12 | $2.89M derived: sum of 2 quarters · filed 2026-08-06 | $4.42M 10-Q · filed 2025-11-12 | $6.17M derived: sum of 4 quarters · filed 2026-08-06 | ||||||
| 2025-06-30 | $1.31M 10-Q · filed 2026-08-06 | $2.85M 10-Q · filed 2026-08-06 | $4.60M derived: sum of 3 quarters · filed 2026-08-06 | $5.71M derived: sum of 4 quarters · filed 2026-08-06 | ||||||
| 2025-03-31 | $1.54M 10-Q · filed 2026-05-12 | $3.28M derived: sum of 2 quarters · filed 2026-05-12 | $4.40M derived: sum of 3 quarters · filed 2026-05-12 | $6.46M derived: sum of 4 quarters · filed 2026-05-12 | ||||||
| 2024-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $2.86M derived: sum of 2 quarters · filed 2026-03-12 | $4.93M derived: sum of 3 quarters · filed 2026-03-12 | $6.70M 10-K · filed 2026-03-12 | ||||||
| 2024-09-30 | $1.11M 10-Q · filed 2025-11-12 | $3.18M derived: sum of 2 quarters · filed 2025-11-12 | $4.96M 10-Q · filed 2025-11-12 | $6.88M derived: sum of 4 quarters · filed 2025-11-12 | ||||||
| 2024-06-30 | $2.06M 10-Q · filed 2025-08-12 | $3.84M 10-Q · filed 2025-08-12 | $5.77M derived: sum of 3 quarters · filed 2025-08-12 | $7.53M derived: sum of 4 quarters · filed 2025-08-12 | ||||||
| 2024-03-31 | $1.78M 10-Q · filed 2025-05-13 | $3.71M derived: sum of 2 quarters · filed 2025-05-13 | $5.46M derived: sum of 3 quarters · filed 2025-05-13 | $7.31M derived: sum of 4 quarters · filed 2025-05-13 | ||||||
| 2023-12-31 | $1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $3.69M derived: sum of 2 quarters · filed 2025-03-18 | $5.53M derived: sum of 3 quarters · filed 2025-03-18 | $7.06M 10-K · filed 2025-03-18 | ||||||
| 2023-09-30 | $1.76M 10-Q · filed 2024-11-12 | $3.61M derived: sum of 2 quarters · filed 2024-11-12 | $5.13M 10-Q · filed 2024-11-12 | $7.18M derived: sum of 4 quarters · filed 2024-11-12 | ||||||
| 2023-06-30 | $1.85M 10-Q · filed 2024-08-13 | $3.37M 10-Q · filed 2024-08-13 | $5.42M derived: sum of 3 quarters · filed 2024-08-13 | $6.68M derived: sum of 4 quarters · filed 2024-08-13 | ||||||
| 2023-03-31 | $1.52M 10-Q · filed 2024-05-09 | $3.57M derived: sum of 2 quarters · filed 2024-05-09 | $4.83M derived: sum of 3 quarters · filed 2024-05-09 | $7.94M derived: sum of 4 quarters · filed 2024-05-09 | ||||||
| 2022-12-31 | $2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $3.31M derived: sum of 2 quarters · filed 2024-03-21 | $6.42M derived: sum of 3 quarters · filed 2024-03-21 | $8.42M 10-K · filed 2024-03-21 | ||||||
| 2022-09-30 | $1.26M 10-Q · filed 2023-11-09 | $4.37M derived: sum of 2 quarters · filed 2023-11-09 | $6.37M 10-Q · filed 2023-11-09 | $8.58M derived: sum of 4 quarters · filed 2023-11-09 | ||||||
| 2022-06-30 | $3.10M 10-Q · filed 2023-08-10 | $5.11M 10-Q · filed 2023-08-10 | $7.32M derived: sum of 3 quarters · filed 2023-08-10 | $9.04M derived: sum of 4 quarters · filed 2023-08-10 | ||||||
| 2022-03-31 | $2.01M 10-Q · filed 2023-05-11 | $4.22M derived: sum of 2 quarters · filed 2023-05-11 | $5.94M derived: sum of 3 quarters · filed 2023-05-11 | $7.36M derived: sum of 4 quarters · filed 2023-05-11 | ||||||
| 2021-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $3.93M derived: sum of 2 quarters · filed 2023-03-22 | $5.35M derived: sum of 3 quarters · filed 2023-03-22 | $6.91M 10-K · filed 2023-03-22 | ||||||
| 2021-09-30 | $1.73M 10-Q · filed 2022-11-09 | $3.14M derived: sum of 2 quarters · filed 2022-11-09 | $4.70M 10-Q · filed 2022-11-09 | $6.07M derived: sum of 4 quarters · filed 2022-11-09 | ||||||
| 2021-06-30 | $1.42M 10-Q · filed 2022-08-11 | $2.98M 10-Q · filed 2022-08-11 | $4.35M derived: sum of 3 quarters · filed 2022-08-11 | $14.97M derived: sum of 4 quarters · filed 2022-08-11 | ||||||
| 2021-03-31 | $1.56M 10-Q · filed 2022-05-12 | $2.93M derived: sum of 2 quarters · filed 2022-05-12 | $13.55M derived: sum of 3 quarters · filed 2022-05-12 | $14.65M derived: sum of 4 quarters · filed 2022-05-12 | ||||||
| 2020-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $11.99M derived: sum of 2 quarters · filed 2022-03-22 | $13.09M derived: sum of 3 quarters · filed 2022-03-22 | $14.37M 10-K · filed 2022-03-22 | ||||||
| 2020-09-30 | $10.62M 10-Q · filed 2021-11-12 | $11.72M derived: sum of 2 quarters · filed 2021-11-12 | $13.00M 10-Q · filed 2021-11-12 | $14.26M derived: sum of 4 quarters · filed 2021-11-12 | ||||||
| 2020-06-30 | $1.10M 10-Q · filed 2021-08-12 | $2.38M 10-Q · filed 2021-08-12 | $3.63M derived: sum of 3 quarters · filed 2021-08-12 | $12.58M derived: sum of 4 quarters · filed 2021-08-12 | ||||||
| 2020-03-31 | $1.29M 10-Q · filed 2021-05-11 | $2.54M derived: sum of 2 quarters · filed 2021-05-11 | $11.49M derived: sum of 3 quarters · filed 2021-05-11 | $12.86M derived: sum of 4 quarters · filed 2021-05-11 | ||||||
| 2019-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $10.20M derived: sum of 2 quarters · filed 2021-03-16 | $11.58M derived: sum of 3 quarters · filed 2021-03-16 | $12.90M 10-K · filed 2021-03-16 | ||||||
| 2019-09-30 | $8.95M 10-Q · filed 2020-11-12 | $10.32M derived: sum of 2 quarters · filed 2020-11-12 | $11.65M 10-Q · filed 2020-11-12 | |||||||
| 2019-06-30 | $1.38M 10-Q · filed 2020-08-12 | $2.71M 10-Q · filed 2020-08-12 | ||||||||
| 2019-03-31 | $1.33M 10-Q · filed 2020-05-14 | |||||||||
| 2018-12-31 | $7.28M 10-K · filed 2020-03-26 | |||||||||
| 2015-03-31 | $1.97M 10-Q · filed 2015-05-20 | $6.19M derived: sum of 2 quarters · filed 2015-05-20 | $9.30M derived: sum of 3 quarters · filed 2015-05-20 | $11.94M derived: sum of 4 quarters · filed 2015-05-20 | ||||||
| 2014-12-31 | $4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | $7.33M derived: sum of 2 quarters · filed 2015-04-15 | $9.97M derived: sum of 3 quarters · filed 2015-04-15 | $12.92M 10-K · filed 2015-04-15 | ||||||
| 2014-09-30 | $3.11M 10-Q · filed 2014-11-14 | $5.75M derived: sum of 2 quarters · filed 2014-11-14 | $8.71M 10-Q · filed 2014-11-14 | $12.26M derived: sum of 4 quarters · filed 2015-07-20 | ||||||
| 2014-06-30 | $2.64M 10-Q · filed 2014-08-14 | $5.60M 10-Q · filed 2014-08-14 | $9.15M derived: sum of 3 quarters · filed 2015-07-20 | |||||||
| 2014-03-31 | $2.96M 10-Q · filed 2015-05-20 | $2.99M 10-Q · filed 2014-05-20 | $6.51M derived: sum of 2 quarters · filed 2015-07-20 | |||||||
| 2013-12-31 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-20 | $9.61M 10-K · filed 2015-07-20 | ||||||||
| 2013-11-30 | $78.94K 10-Q · filed 2014-01-10 | |||||||||
| 2013-09-30 | $2.53M 10-Q · filed 2014-11-14 | $6.06M 10-Q · filed 2014-11-14 | ||||||||
| 2013-08-31 | $64.08K derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $162.46K 10-K · filed 2013-11-27 | ||||||||
| 2013-06-30 | $2.03M 10-Q · filed 2014-08-14 | $3.53M 10-Q · filed 2014-08-14 | ||||||||
| 2013-05-31 | $39.81K 10-Q · filed 2013-07-17 | $98.38K 10-Q · filed 2013-07-17 | $335.20K 10-Q · filed 2013-07-17 | |||||||
| 2013-03-31 | $1.39M 10-Q · filed 2014-05-20 | |||||||||
| 2013-02-28 | $14.31K 10-Q · filed 2013-04-22 | $58.56K 10-Q · filed 2013-04-22 | $125.35K derived: sum of 3 quarters · filed 2014-01-10 | $197.41K derived: sum of 4 quarters · filed 2014-01-10 | $295.38K 10-Q · filed 2013-04-22 | |||||
| 2012-12-31 | $6.59M 10-K · filed 2015-07-20 | |||||||||
| 2012-11-30 | $44.25K 10-Q · filed 2014-01-10 | $111.04K derived: sum of 2 quarters · filed 2014-01-10 | $183.09K derived: sum of 3 quarters · filed 2014-01-10 | $245.13K derived: sum of 4 quarters · filed 2014-01-10 | ||||||
| 2012-08-31 | $66.79K derived: 10-K 12 month − 10-Q 9 month · filed 2013-11-27 | $138.85K derived: sum of 2 quarters · filed 2013-11-27 | $200.88K derived: sum of 3 quarters · filed 2013-11-27 | $229.45K 10-K · filed 2013-11-27 | ||||||
| 2012-05-31 | $72.06K 10-Q · filed 2013-07-17 | $134.09K derived: sum of 2 quarters · filed 2013-07-17 | $162.66K 10-Q · filed 2013-07-17 | $170.03K 10-Q · filed 2012-07-16 | ||||||
| 2012-02-29 | $62.03K 10-Q · filed 2013-04-22 | $90.60K 10-Q · filed 2013-04-22 | $97.97K 10-Q · filed 2012-04-24 | |||||||
| 2011-11-30 | $28.57K 10-Q · filed 2013-01-22 | |||||||||
| 2011-08-31 | $7.38K 10-K · filed 2012-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |